IPS Genomix stands for innovation that benefits to the community. Specialized in the latest prognostic, predictive and personalized medicine, IPS Genomix gives treating physicians access to important and clinically relevant genomic information further to testing human specimens (tissue, blood, saliva, buccal swab…) in the European or US partnering laboratories accredited and specialized in this field.

The treating physician can then individualize the treatment of his/her patients to enhance the prevention and/or treatment of certain conditions and diseases. IPS Genomix brings this intelligent and groundbreaking new solution to treating physicians and their patients in the Middle East and Africa thanks to partnerships with multinational companies.

Given the rapid evolution of this particular field, IPS Genomix constantly incorporates new technology platforms and assays to offer physicians and their patients with the most up to date, reliable and cutting edge personalized medicine tools.


Ahmed Yacout
Chairman and CEO – IPS Group
Ahmed Yacout is the founder of IPS Group and boasts decades of experience in the field mainly in the MENA region. Pri ...

Ahmed Yacout

Chairman and CEO – IPS Group
Ahmed Yacout is the founder of IPS Group and boasts decades of experience in the field mainly in the MENA region. Prior to IPS, he was the General Manager of Sanofi Near East. He launched his career in the pharmaceutical industry in 1984 in Egypt with Roussel Uclaf before moving to Rhone Poulenc Rorer (RPR).

His vision goes over and above pharmaceutical solutions. It leads him to drive the regional market with innovative and progressive solutions. He wants IPS to “Become, with the support of its highly-experienced people, the game changers of the region.”

A strategist and a results-oriented professional, he has the essential know-how needed to grow the business and predict potential market opportunities.

He founded IPS on the belief that, “Patients are the core of our presence and if we position ourselves in their shoes, we will strive to serve them better.”
Rima Helou
Chief Operating Officer - IPS Genomix
Rima Helou is the COO of IPS Genomix and previously the General Manager of a leading multinational pharmaceutical com ...

Rima Helou

Chief Operating Officer - IPS Genomix
Rima Helou is the COO of IPS Genomix and previously the General Manager of a leading multinational pharmaceutical company. Dr Helou has a successful track record of over 15 years of experience in marketing, sales and business unit management in the Levant region. A Doctor of Pharmacy with an impressive background in business, she propels this innovative division of IPS forward.
Sylvana L Nader
Chief People Officer – IPS Group
Sylvana Nader boasts over 15 years of experience in professional human capital management in diverse industries: phar ...

Sylvana L Nader

Chief People Officer – IPS Group
Sylvana Nader boasts over 15 years of experience in professional human capital management in diverse industries: pharmaceutical, healthcare, banking, insurance and technology. Before joining IPS, she was the Human Resources Director for the Near East Region at Sanofi and the Head of Human Resources at American Express Bank. She is highly adept at leading change and transformation initiatives, thus helping to build deep rooted corporate cultures and strong teams.
Selim Chami
Chief Investment Officer– IPS Holding
Selim Chami has over fifteen years of banking experience out of which he spend the last ten years providing investme ...

Selim Chami

Chief Investment Officer– IPS Holding
Selim Chami has over fifteen years of banking experience out of which he spend the last ten years providing investment banking advisory services and capital raising with deals originating from Europe to the Middle East. Prior to joining IPS, he was heading the investment banking services as deputy General Manager at BSEC-Structured Finance. He previously held different positions such as Senior Executive Manager at Qatar Islamic Bank where he was heading the structured finance and international finance business, and as a Senior Consultant at Deloitte & Touche Enterprise Risk Services division in the Middle East.

His investment banking experience spans across financial services including M&A, private placements, securitization, project finance, syndication, and investments in private equity funds, mutual funds, real estate, etc.

Selim holds a Bachelor of Civil Engineering from ESIB (Lebanon) and a Masters from Ecole Superieure de Commerce de Paris.”
Rania Khoury
Head of Medical Middle East & Africa - IPS Genomix
Rania Khoury is the Head of Medical of IPS Genomix. Her role is to make unique contributions to the field of human ge ...

Rania Khoury

Head of Medical Middle East & Africa - IPS Genomix
Rania Khoury is the Head of Medical of IPS Genomix. Her role is to make unique contributions to the field of human genetics and genomics and to complement the work of other healthcare providers to improve the health of the patients.
Previously has been the Marketing Manager of IPS Genomix. Her major contribution was to accelerate the delivery and uptake of personalized medicine and innovative diagnostics solutions for the community in the Middle East and Africa region in order to improve patient care.
Rania has been working for more than 15 years in the marketing and sales functions at Sanofi in the Near East region. Her expertise in the project management as well has led to more involvement in health awareness campaigns dealing with NGOs and health authorities.
Rania holds a Doctorate in Pharmacy from St Joseph University of Beirut (USJ) and a diploma in Health Leadership and Management from the American University of Beirut (AUB).
She believes that greater collaboration will be needed across a wide range of actors in healthcare in order to catch up with science advances.